Clinical trial
Prospective, Randomized, Double-Blind, Active-Controlled, Multicenter Trial of Bivalirudin and Un-fractionated Heparin in Patients Undergoing Percutaneous Coronary Interventions. ISAR-REACT-3
NCT00262054 is registered in ClinicalTrials.gov with Deutsches Herzzentrum Muenchen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Randomized, Double-Blind, Active-Controlled, Multicenter Trial of Bivalirudin and Un-fractionated Heparin in Patients Undergoing Percutaneous Coronary Interventions. ISAR-REACT-3
- Lead sponsor
- Deutsches Herzzentrum Muenchen
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2005
- Completion date
- May 31, 2008
- Enrollment
- 4,570 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.